Ontology highlight
ABSTRACT: Background
Low myocardial cGMP-PKG (cyclic guanosine monophosphate-protein kinase G) activity has been associated with increased cardiomyocyte diastolic stiffness in heart failure with preserved ejection fraction. Cyclic guanosine monophosphate is mainly hydrolyzed by PDE (phosphodiesterases) 5a and 9a. Importantly, PDE9a expression has been reported to be upregulated in human heart failure with preserved ejection fraction myocardium and chronic administration of a PDE9a inhibitor reverses preestablished cardiac hypertrophy and systolic dysfunction in mice subjected to transverse aortic constriction (TAC). We hypothesized that inhibiting PDE9a activity ameliorates diastolic dysfunction.Methods
To examine the effect of chronic PDE9a inhibition, 2 diastolic dysfunction mouse
SUBMITTER: Methawasin M
PROVIDER: S-EPMC7895451 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature